GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigen Vaccine Biologics Corp (ROCO:6547) » Definitions » Other Stockholders Equity

Medigen Vaccine Biologics (ROCO:6547) Other Stockholders Equity : NT$176.3 Mil (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Medigen Vaccine Biologics Other Stockholders Equity?

Medigen Vaccine Biologics's Other Stockholders Equity for the quarter that ended in Mar. 2025 was NT$176.3 Mil.

Medigen Vaccine Biologics's quarterly Other Stockholders Equity increased from Sep. 2024 (NT$231.5 Mil) to Dec. 2024 (NT$235.6 Mil) but then declined from Dec. 2024 (NT$235.6 Mil) to Mar. 2025 (NT$176.3 Mil).

Medigen Vaccine Biologics's annual Other Stockholders Equity declined from Dec. 2022 (NT$223.6 Mil) to Dec. 2023 (NT$169.3 Mil) but then increased from Dec. 2023 (NT$169.3 Mil) to Dec. 2024 (NT$235.6 Mil).


Medigen Vaccine Biologics Other Stockholders Equity Historical Data

The historical data trend for Medigen Vaccine Biologics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigen Vaccine Biologics Other Stockholders Equity Chart

Medigen Vaccine Biologics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.35 -0.46 223.60 169.34 235.58

Medigen Vaccine Biologics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 167.64 223.77 231.53 235.58 176.27

Medigen Vaccine Biologics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Medigen Vaccine Biologics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Medigen Vaccine Biologics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Medigen Vaccine Biologics Business Description

Traded in Other Exchanges
N/A
Address
No.68, Shengyi 3rd Road, Hsinchu County, Zhubei, TWN, 30261
Medigen Vaccine Biologics Corp is a biopharmaceutical company focusing on developing and producing vaccines and biologics. It is engaged in developing IP-protected cell-culture technologies for vaccine manufacturing. The company develops vaccines and affordable biosimilars to prevent regional infectious diseases. The group generates revenue from manufacturing and selling a range of COVID-19 vaccines and COVID-19 test kits and provides technical services on cellular therapy product quality and cell culture tests.

Medigen Vaccine Biologics Headlines

No Headlines